
    
      Healthy volunteers are administrated single-dose over the period I and II (crossover) of
      CGL1802(Polmacoxib 2mg Tablet) and CG1801(Polmacoxib 2mg capsule) Every time before and after
      each medication, pharmacokinetic (PK) parameters and safety of CGL1802 and CG1801 is
      performed using a blood sample and conducting some tests (vital signs, physical exam, ECG,
      laboratory test, etc.) respectively.
    
  